Writer Robin Robinson featured insight from five industry sources, including Rob Bazemore, President of Janssen Biotech; Chris Bogan, CEO of Best Practices; Andrew Hunter, Senior Manager of Kalypso; Mike Rea, CEO of IDEA Pharma; and yours truly.

I encourage you to grab a copy of this month's PharmaVOICE or flip over to the digital edition (page 8) to read the piece.
Find out the three major themes Robin distilled from our collective insight, and what it means for your PLM strategy as we prepare for 2012.
No comments:
Post a Comment